These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34944481)

  • 1. Which Properties Allow Ligands to Open and Bind to the Transient Binding Pocket of Human Aldose Reductase?
    Sandner A; Ngo K; Sager CP; Scheer F; Daude M; Diederich WE; Heine A; Klebe G
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational Analysis.
    Rechlin C; Scheer F; Terwesten F; Wulsdorf T; Pol E; Fridh V; Toth P; Diederich WE; Heine A; Klebe G
    ACS Chem Biol; 2017 May; 12(5):1397-1415. PubMed ID: 28287700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a novel binding site conformer of aldose reductase in ligand-bound state.
    Steuber H; Zentgraf M; La Motta C; Sartini S; Heine A; Klebe G
    J Mol Biol; 2007 May; 369(1):186-97. PubMed ID: 17418233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and thermodynamic study on aldose reductase: nitro-substituted inhibitors with strong enthalpic binding contribution.
    Steuber H; Heine A; Klebe G
    J Mol Biol; 2007 May; 368(3):618-38. PubMed ID: 17368668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.
    Steuber H; Zentgraf M; Podjarny A; Heine A; Klebe G
    J Mol Biol; 2006 Feb; 356(1):45-56. PubMed ID: 16337231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
    Steuber H; Heine A; Podjarny A; Klebe G
    J Mol Biol; 2008 Jun; 379(5):991-1016. PubMed ID: 18495158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of human aldose reductase holoenzyme in complex with statil: an approach to structure-based inhibitor design of the enzyme.
    El-Kabbani O; Ramsland P; Darmanin C; Chung RP; Podjarny A
    Proteins; 2003 Feb; 50(2):230-8. PubMed ID: 12486717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the inhibitor-binding site of porcine aldehyde reductase: crystal structure of the holoenzyme-inhibitor ternary complex.
    el-Kabbani O; Carper DA; McGowan MH; Devedjiev Y; Rees-Milton KJ; Flynn TG
    Proteins; 1997 Oct; 29(2):186-92. PubMed ID: 9329083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing flexibility and "induced-fit" phenomena in aldose reductase by comparative crystal structure analysis and molecular dynamics simulations.
    Sotriffer CA; Krämer O; Klebe G
    Proteins; 2004 Jul; 56(1):52-66. PubMed ID: 15162486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.
    Urzhumtsev A; Tête-Favier F; Mitschler A; Barbanton J; Barth P; Urzhumtseva L; Biellmann JF; Podjarny A; Moras D
    Structure; 1997 May; 5(5):601-12. PubMed ID: 9195881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Determinants of the Selectivity of 3-Benzyluracil-1-acetic Acids toward Human Enzymes Aldose Reductase and AKR1B10.
    Ruiz FX; Cousido-Siah A; Porté S; Domínguez M; Crespo I; Rechlin C; Mitschler A; de Lera ÁR; Martín MJ; de la Fuente JÁ; Klebe G; Parés X; Farrés J; Podjarny A
    ChemMedChem; 2015 Dec; 10(12):1989-2003. PubMed ID: 26549844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies for the design of inhibitors of aldose reductase, an enzyme showing pronounced induced-fit adaptations.
    Klebe G; Krämer O; Sotriffer C
    Cell Mol Life Sci; 2004 Apr; 61(7-8):783-93. PubMed ID: 15095003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual screening for inhibitors of human aldose reductase.
    Kraemer O; Hazemann I; Podjarny AD; Klebe G
    Proteins; 2004 Jun; 55(4):814-23. PubMed ID: 15146480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding.
    Podjarny A; Cachau RE; Schneider T; Van Zandt M; Joachimiak A
    Cell Mol Life Sci; 2004 Apr; 61(7-8):763-73. PubMed ID: 15095001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal packing modifies ligand binding affinity: the case of aldose reductase.
    Cousido-Siah A; Petrova T; Hazemann I; Mitschler A; Ruiz FX; Howard E; Ginell S; Atmanene C; Van Dorsselaer A; Sanglier-Cianférani S; Joachimiak A; Podjarny A
    Proteins; 2012 Nov; 80(11):2552-61. PubMed ID: 22752989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific interaction of a novel spirosuccinimide type aldose reductase inhibitor, AS-3201, with aldose reductase.
    Kurono M; Fujiwara I; Yoshida K
    Biochemistry; 2001 Jul; 40(28):8216-26. PubMed ID: 11444967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based optimization of aldose reductase inhibitors originating from virtual screening.
    Eisenmann M; Steuber H; Zentgraf M; Altenkämper M; Ortmann R; Perruchon J; Klebe G; Schlitzer M
    ChemMedChem; 2009 May; 4(5):809-19. PubMed ID: 19301313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Halogen-to-Hydrogen Bond Substitution on Human Aldose Reductase Inhibition.
    Fanfrlík J; Ruiz FX; Kadlčíková A; Řezáč J; Cousido-Siah A; Mitschler A; Haldar S; Lepšík M; Kolář MH; Majer P; Podjarny AD; Hobza P
    ACS Chem Biol; 2015 Jul; 10(7):1637-42. PubMed ID: 25919404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.